Molecular Mechanisms of Candida auris Adhesion to Abiotic Surfaces
耳念珠菌粘附非生物表面的分子机制
基本信息
- 批准号:10601671
- 负责人:
- 金额:$ 4.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAdhesivesAntifungal AgentsAutomobile DrivingBacterial AdhesinsCandida albicansCandida aurisCase StudyCell surfaceCell-Matrix JunctionCellsChromatinChromatin Remodeling FactorClinicalCollectionData SetDecontaminationDevelopmentDiseaseDisease OutbreaksDisinfectantsExcisionFamilyFoundationsGene FamilyGenesGeneticGenetic TranscriptionGenomeGenomicsGoalsHealthcareHomologous GeneHospitalsHydrophobic SurfacesImplantIncidenceIndividualInfectionInfection ControlInfection preventionInterventionKnowledgeLinkMeasuresMediatingMedical DeviceMicrobial BiofilmsMolecularMulti-Drug ResistanceOutcomePatientsPhenotypePopulationPredispositionProcessProteinsProtocols documentationRegulationResearchResistanceStructureSurfaceTestingTranscriptional RegulationVariantVirulenceburden of illnesscell typedesigndifferential expressionfungusgenetic variantgenome wide association studymembermolecular scalemutantnoveloverexpressionpathogenic fungusprevention practiceresistant straintranscription factortranscriptomicstransmission process
项目摘要
Abstract
Candida auris is an emerging fungal pathogen responsible for invasive, often multidrug-resistant infections and
outbreaks worldwide. Unlike for many other fungal pathogens, C. auris infection is primarily nosocomial, driven
by the propensity of C. auris to robustly colonize medical devices, implants, and abiotic surfaces that are
proximal to patient quarters. C. auris can survive on abiotic surfaces for weeks, and many strains are resistant
to commonly used antifungals and disinfectants, hindering decontamination efforts. The importance of this
colonization to C. auris disease spread is demonstrated by intervention case studies associating reduction of
infection incidence with removal of colonized fomites. C. auris can also form biofilms on surfaces, likely
contributing to its resistance to decontamination. On a molecular scale, these processes require the initial first
step of individual fungal cells physically attaching to a surface. While the regulation of attachment has been
explored to a limited extent in related fungal species, no mechanistic studies have investigated the molecular
machinery governing initial attachment in C. auris. Furthermore, while C. auris encodes genes homologous to
characterized Candida albicans ALS and IFF/HYR family adhesins, proteins which have been implicated in
attachment in other fungal species, our findings indicate none of these genes substantially contributes to
attachment to abiotic surfaces in C. auris. Instead, we have identified B9J08_001458, a novel class of adhesin
specifically encoded by C. auris with no characterized homologs. Deletion of B9J08_001458 substantially and
significantly reduces C. auris adhesion. Furthermore, our preliminary findings suggest natural transcriptional
variation of B9J08_001458 among C. auris isolates is linked to natural variation in adhesive potential. The goal
of this proposal is to identify the functional and regulatory mechanisms of C. auris adhesion and explain the
variability in adhesion in different C. auris clinical isolates. Our hypothesis is that C. auris regulates an
adhesive cell surface profile primarily through expression of the putative novel adhesin B9J08_001458,
and that transcriptional control of this adhesin explains adhesive variation amongst C. auris isolates.
To address this hypothesis, we will leverage our global genetic and transcriptomic datasets to identify
transcription factors targeting B9J08_001458. Our findings also suggest B9J08_001458 is regulated through
the SWI/SNF chromatin remodeling complex; we will characterize this layer of transcriptional regulation by
comparing chromatin states between wild type cells and mutants deficient in SWI/SNF function. We will then
investigate the impact of genetic variants driving differential expression of B9J08_001458 amongst diverse C.
auris isolates using genome wide association studies. The findings of this proposal will provide a scientific
foundation for the rational development of decontamination and infection control protocols against C. auris,
potentially mitigating the disease burden of this fungus.
摘要
耳念珠菌是一种新出现的真菌病原体,可引起侵袭性,通常是多药耐药感染,
全球爆发。与许多其他真菌病原体不同,C.耳感染主要是医院感染,
由C.耳,以稳健地定殖医疗设备、植入物和非生物表面,
靠近病人区C.耳虱可以在非生物表面存活数周,许多菌株具有抵抗力。
通常使用的抗真菌剂和消毒剂,阻碍了净化工作。这一点的重要性
殖民地C.与减少听力相关的干预案例研究证明了耳疾病的传播
感染发生率与移走定植污染物。C.耳也可以在表面形成生物膜,
有助于其抵抗去污。在分子尺度上,这些过程需要最初的第一个
单个真菌细胞物理附着到表面的步骤。虽然对扣押的规定一直是
在相关真菌物种中进行了有限程度的探索,没有机制研究调查了分子生物学。
在C中控制初始附着的机械。耳。此外,C. auris编码的基因与
特征性的白色念珠菌ALS和IFF/HYR家族粘附素,这些蛋白质与
附着在其他真菌物种,我们的研究结果表明,这些基因都没有实质性贡献
附着在非生物表面的C.耳。相反,我们已经鉴定了B9J08_001458,一种新的粘附素
由C编码。没有特征性同源物的耳。B9J08_001458实质性缺失,
大大降低了C。耳粘连此外,我们的初步研究结果表明,自然转录
B9J08_001458在C.耳分离株与粘附力的自然变化有关。目标
本研究的目的是明确C.耳粘连并解释
不同C.耳临床分离株。我们的假设是C.耳调节
粘附细胞表面特征主要通过推定的新型粘附素B9J08_001458的表达,
这种粘附素的转录调控解释了C.耳分离物。
为了解决这个假设,我们将利用我们的全球遗传和转录组数据集来识别
靶向B9J08_001458的转录因子。我们的研究结果还表明,B9J08_001458通过以下途径调节:
SWI/SNF染色质重塑复合物;我们将通过以下方式表征这一层的转录调控:
比较野生型细胞和SWI/SNF功能缺陷突变体之间的染色质状态。然后我们将
研究驱动B9J08_001458在不同C.
使用全基因组关联研究的auris分离物。这项提案的结果将提供一个科学的
为合理制定C.耳,
可能减轻这种真菌的疾病负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darian Jay Santana其他文献
Darian Jay Santana的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 4.13万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 4.13万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 4.13万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 4.13万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 4.13万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 4.13万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 4.13万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 4.13万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 4.13万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 4.13万 - 项目类别: